This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Co-authored by Dinesh Kashyap. If you’ve been involved in a start-up of a clinical study, you’re probably aware of the challenges that come with patient recruitment. An Area of Opportunity. Patient recruitment is one of the biggest bottlenecks in clinical research. According to the National Institutes of Health (NIH), more than 80% of clinical trials in the United States fail to meet their patient recruitment timelines.
Many of us are now working from home. We’re accepting meeting invites that will be held via video conference and preparing to FaceTime our families after work. We are pivoting our lifestyles to fit the circumstances that COVID-19 has put us in. After lockdowns, isolations, and closures, we are starting to see the nation prepare to reopen. While New York City was one of the most severe areas for the pandemic, other regions of the state are ready to leave isolation.
ABOUT AUTHORS. Swarupananda Mukherjee*, Sohini Bera, Moumoyee Chakraborty . NSHM Knowledge Campus, Kolkata – Group of Institutions, Department of Pharmaceutical Technology, 124, B L Saha Road, Kolkata, India * Swarupananda.mukherjee@nshm.com. ABSTRACT : Corona viruses are a family of enveloped, positive stranded, single stranded RNA viruses. This corona virus family consists of pathogens of several human and animal species including SARS-CoV, NovelCOVID-19 but now referred to as SARS-CoV-2 by th
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
The purpose of this document is to outline some of the HIPAA Security Rule’s standards for protecting electronic protected health information (ePHI), and introduce how some features of the Salesforce Services may help Customers keep ePHI secure in the cloud and considerations on solution implementation approach covering Salesforce Marketing Cloud, Salesforce Health Cloud, and Salesforce Community Cloud for the purposes of early phase clinical trials patient recruitment solution.
RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. John Mack (PG): Thanks for the interview and I really appreciate talking about myself, but enough about me tell me about you and what you plan to do with pharma marketing?
June Pandemic Update Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Send in a voice message: [link]
June Pandemic Update Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Send in a voice message: [link]
Client-Pharma is delighted to welcome Clinical Trial Project Manager, Marcia Goncalves to the team. Originally from Brazil, Marcia brings extensive experience of clinical trial supplies to the global pharmaceuticals sector. The supply chain for global comparator systems is multi-faceted and it is absolutely critical that each project maintains a fully compliant, efficient and secure process at every step, across many borders.
The TrialKit platform received updates to its eConsent and ePRO modules to advance remote data collection and management. Crucial Data Solutions, Inc. (CDS), a provider of innovative software to advance clinical research, announced today a number of enhancements to their data collection and study management platform, TrialKit. The platform’s electronic informed consent (eConsent) and electronic patient-reported outcomes (ePRO) modules were updated to optimize efficiency, enable enhanced workflow
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The global pandemic has changed the way we think about research. Sponsors should consider how the "new normal" will impact sites and current studies as they plan to re-start research.
For 2020 the BIO International Convention, usually one the world’s largest gatherings of the global biotech industry, is transitioning to a new, virtual event format. Drug Discovery Today’s Steve Carney will moderate a discussion on how advanced data science technologies such as artificial intelligence and machine learning (AI/ML) can be developed to assist drug discovery.
Today’s guest post comes from Julia Phillips, VP, Pharma Accounts & Enablement at CoverMyMeds. Julia discusses how medication access challenges can negatively impact brand-name drugs. For more, check out this overview of CoverMyMeds' technology solutions that enhance patients’ access: Enabling Medication Access Through Technology. Read on for Julia’s insights.
From Dallas and Hesitant About Clinical Research Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Sen
Client-Pharma is delighted to welcome Clinical Trial Project Manager, Marcia Goncalves to the team. Originally from Brazil, Marcia brings extensive experience of clinical trial supplies to the global pharmaceuticals sector. The supply chain for global comparator systems is multi-faceted and it is absolutely critical that each project maintains a fully compliant, efficient and secure process at every step, across many borders.
Webinar information:Join the experts on this free exclusive webinar on the 16th July 2020 at 2pm BST, hosted by West Pharmaceutical Services, Inc. As the industry continues to see significant growth for drug products developed in prefilled syringe systems (PFS), there is a trend for pharmaceutical companies to evaluate more complex drug molecules, such as biologics.This webinar discusses current trends in the market for injectable drug delivery and outlines current challenges for companies devel
The 340B Drug Pricing Program has logged another year of incredible growth. According to data provided to Drug Channels by the Health Resources and Services Administration (HRSA), discounted 340B purchases were at least $29.9 billion in 2019. That figure is an astonishing 23% higher than its 2018 counterpart. Since 2014, purchases under the 340B program have tripled.
From Dallas and Hesitant About Clinical Research. Don't forget to Subscribe for new content! Subscribe: [link] Call or Text: 910-502-3732 Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education.
RJ (PMN): Hi this is RJ Lewis, your host of the pharma marketing network podcast and I’m excited today to have with me a couple of executives from Klick Health to talk about CCPA. We have Holly Henry on the phone who is the chief medical officer of klick, and we also have Kamran Shah who is the EVP of technology and media. Welcome to the podcast!
ABOUT AUTHORS. BHANDARI SALONI *, KISHNANI KHUSHBOO, RATHORE KAMAL SINGH . BN College of Pharmacy, Udaipur-Raj. 313001. salonibhandari1996.sb@gmail.com. ABSTRACT. Liposomes are concentric bilayer vesicles, which were first developed by Bangham and his colleagues in 1961. They are highly efficient having high drug entrapment capacity. Due to their size, hydrophobic and lipophilic character they are most widely used vehicles for drug delivery.
On May 22, 2020, the Federal Court granted a motion seeking an order that the issue of infringement in an action brought pursuant to section 6 of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ) would not be moot notwithstanding that the trial was set to proceed after the expiry of the relevant patent. Background. Sandoz served a Notice of Allegation on AstraZeneca alleging non-infringement, invalidity and ineligibility for listing of AstraZeneca’s patent for saxagliptin
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Don (PMN): Hi good morning everyone, welcome to the pharma marketing podcast. I’m your host Don Langsdorf and I am here today with Bob Baurys and Mark Stinson from 83Bar and also the authors of patient activation. Bob and Mark thanks for joining us today. Bob (83Bar): Great to be here. Mark (83Bar): Yea thank you. Don (PMN): Wonderful. I think it would help our listeners to know a little bit about you first before we jump into the meat of the interview here.
Generally, I strongly support the World Health Organization (WHO) and its unambiguously important work to save lives through its public health efforts. The backlash against it in the U.S. is simultaneously misguided and politically motivated. I know why. It detracts from our failures in the U.S. to save lives, but there is more to the story. Republicans generally have a greater hostility to international organizations because they view them as tying our hands and/or taking our money to help peop
Michelle Andrews. June 1, 2020. The economic upheaval and social disruption caused by the coronavirus pandemic have upended the assumptions many people made last fall about which insurance plan to sign up for, or how much of their pretax wages to sock away in health or dependent care flexible spending accounts. You may find yourself in a high-priced health plan you can no longer afford because of a temporary pay cut, unable to get the medical care you might have planned and budgeted for, or not
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
RJ Lewis (EHS): Hello, this is RJ Lewis, the Founder, and CEO of eHealthcare Solutions. And I’m excited about today’s podcast. With me, today is John Mack, the original creator of Pharma Marketing and also known as Pharma Guy from far and wide. And I also have with me Don Langsdorf who’s our Director of Digital Solutions and Strategy.
RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. I’ll be your host today. And I am very excited to have with us, Ritesh Patel. Ritesh sure most of you know him already. He’s known industry-wide. He’s the Chief Digital Officer for Health at Ogilvy. And he’s also a Pharma Marketing Network Editorial Advisory Board member.
RJ Lewis (EHS): Hello, this is RJ Lewis from Pharma Marketing Network. I’ll be your host today. And I am very excited to have with us, Ritesh Patel. Ritesh sure most of you know him already. He’s known industry-wide. He’s the Chief Digital Officer for Health at Ogilvy. And he’s also a Pharma Marketing Network Editorial Advisory Board member.
Don (PMN): Hi welcome. This is Don Langsdorf with the Pharma Marketing Network pleased to welcome today Dave Chase, co-founder of the Health Rosetta. Good morning, Dave. Thanks for coming on the podcast and if you wouldn’t mind, could tell us a little bit about yourself. Dave (HR): Sure. Thanks for having me on. Quick background on myself. I started my career in consulting implementing systems inside of a couple dozen different hospitals and then I went on to find Microsoft’s healthc
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
125 
Let's personalize your content